AlphAIAlphAI — Financial news for AI agents
investing.comOCT 222 min read$IBM

UBS raises IBM stock price target to $243 on mixed Q3 results

UBS raised IBM's price target to $243 from $236, maintaining a Neutral rating. IBM reported mixed Q3 2026 results, beating revenue and EPS estimates. Revenue grew 6% in constant currency, driven by software and infrastructure. Gross margin missed estimates. Stifel raised its target to $260, citing strong performance. IBM reiterated its 2026 revenue growth guidance of 4% to 5%.

Original reporting
investing.com
Published Oct 22, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$IBM
Bearish
high confidence
Mentioned
$IBM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$IBMBearishHigh
01

Why it matters

The earnings release and target adjustment provide fresh data for traders to reassess IBM's valuation.

02

Market read

IBM's earnings and analyst target change are the primary drivers of short-term price action.

03

What to watch

The upcoming Confluent acquisition benefits in 2027 may not be fully priced in yet.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

IBM reported Q3 2026 earnings, beating estimates, but analysts lowered price targets citing margin pressure and modest guidance.

Company-level read

Ticker impact

$IBMBearishHigh confidence
Context

UBS raised IBM's price target to $243 and reported mixed Q3 2026 results with earnings beat and guidance updates.

Expected impact

likely pressure as the market prices in the lower price target and modest guidance

Evidence & confidence

The price target cut below current price and modest guidance imply investors may sell, especially after earnings.

Market effects

Sector

Software and infrastructure segments may see broader scrutiny as IBM's mixed results highlight margin pressures.

Regional

U.S. tech sector could face slight pullback amid analyst target revisions.

Global

Limited to large-cap tech investors; no immediate global macro effect.

Counterpoint

What could challenge this read

Despite the target cut, IBM's cash flow outlook and mainframe strength could support a rebound.

Key entities

  • Company
    IBM

    International Business Machines Corporation, provider of hardware, software, and services.

  • Analyst
    UBS

    Investment bank that raised IBM's price target to $243.

Read at source← All news

StoryIBM reports Q3 2026 revenue of $17.1 B, beats estimates and lifts free‑cash‑flow outlook

Also covered by

6 outlets

Related articles

OCT 23
$IBMMed

IBM SWOT Analysis: Strong Revenue Growth Amidst Competitive Chal

IBM reported Q3 2026 revenue of $17.1B, up 4.7% YoY. Software segment grew to $8B, driven by hybrid cloud and AI. R&D investment was $2.4B. Debt stands at $7B, with a GF Score of 76/100. Stock is overvalued at $252.11 vs. GF Value of $243.46. Opportunities include hybrid cloud and AI demand, while threats include competition and economic downturns.

gurufocus.com2 min
OCT 22
$IBMHighAI 8/10

IBM Stocks Drop 2.17% Despite Software-Led Beat

IBM's Q3 revenue rose 5% to $17.1B, driven by 8% software growth, but shares fell 2.17% to $246.01. The company raised its full-year free cash flow outlook by over $1B. Consulting revenue remained flat, and analysts questioned the sustainability of software growth. IBM's valuation is near fair value, according to Reuters.

gurufocus.com2 min
OCT 22
$IBMMedAI 8/10

IBM's Software Rebound Comes With a Catch

IBM reported Q3 revenue of $17.10B, up 4.7%, and adjusted profit of $2.95 per share, exceeding estimates. Software revenue rose 8% and hybrid cloud sales increased 11%, leading IBM to raise its annual software growth outlook to 7-8%. However, some of the growth came from deferred contracts, raising questions about sustainability.

gurufocus.com2 min
OCT 22
$IBMHighAI 8/10

IBM earnings analysis: questions answered and next catalysts

IBM reported Q3 2026 earnings beating estimates with revenue of $17.10B and EPS of $2.95. The company maintained its full-year revenue guidance, leading to a 6% pre-market drop in shares, which partially recovered to $248.72. Software growth accelerated to 9%, and free cash flow outlook was raised. Key concerns include the quality of software growth, mainframe cycle, and consulting segment performance. Next catalysts include Q4 and FY2026 results, 2027 guidance, and margin delivery.

investing.com3 min